Dr. John Chen, postdoctoral fellow in the Kampmann lab, won a QB3/Calico Longevity Fellowship. John works with Diane Nathaniel in the lab to uncover cellular pathways controlling aggregation and prion-like spread of the protein tau, which is associated with Alzheimer’s Disease, frontotemporal dementia, and other neurodegenerative diseases. Pathways identified in this research may guide the development of new therapeutic strategies. The team is using an innovative, CRISPR-based functional genomics approach co-developed by Dr. Kampmann. The funding from the QB3/Calico program will support the implementation of these experiments in human iPSC-derived neurons. Congratulations!